Hereditary transthyretin amyloidosis polyneuropathy in patients with carpal tunnel syndrome in Russia

Trial Identifier: D8451R00001
Sponsor: AstraZeneca
Start Date: December 2023
Primary Completion Date: March 2025
Study Completion Date: March 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Arkhangelsk, Russia
Russia Barnaul, Russia
Russia Chelyabinsk, Russia
Russia Irkutsk, Russia
Russia Kazan, Russia
Russia Krasnodar, Russia
Russia Moscow, Russia
Russia Nizhny Novgorod, Russia
Russia Rostov on Don, Russia
Russia Saint Petersburg, Russia
Russia Samara, Russia
Russia Ufa, Russia
Russia Yekaterinburg, Russia